Vyne Pharmaceuticals Inc.

NJ · United States · Reporting entity ID 100000806848

Total reported 2019–2025

$5.04M

#704 of 2,960 reporting companies — 0% of all reported industry payments

$1.93M in general payments across 25,872 records, plus $3.11M in research funding across 921 records.

How it breaks down

General payments $1,930,594

Research funding $3,106,437

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.